Clinical Trials Directory

Trials / Completed

CompletedNCT04169516

Localization of Microvascular Dysfunction

Different Microcirculation Response to Ischemic Injury of Culprit and Non-culprit

Status
Completed
Phase
Study type
Observational
Enrollment
115 (actual)
Sponsor
Dong-A University · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers

Summary

Microvascular dysfunction is an independent predictor of poor prognosis. Such response in the culprit vessel is common even after successful revascularization. This study investigated whether the microvascular dysfunction differed between culprit and non-culprit vessels in patients with acute coronary syndrome (ACS) who underwent percutaneous coronary intervention (PCI).

Detailed description

The prospective study included 115 patients with ACS. In this study, after successful PCI, culprit and non-culprit intracoronary hemodynamic measurements were performed and repeated at 6-month follow-up. 13N-ammonia positron emission tomography (PET) was performed at 6-month follow-up visit to determine absolute myocardial blood flow (MBF). The resistance values of each vessel were calculated using the coronary pressure data and the MBF values obtained from 13N-ammonia PET data. Such physiological measures were compared between culprit and non-culprit vessels in baseline and 6-month follow-up.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTindex of microcirculatory resistancePhysiological parameters of the culprit artery after PCI were determined with the restoration of Thrombolysis in Myocardial Infarction (TIMI) 3 flow. Aortic pressure (Pa), distal intracoronary pressure (Pd), fractional flow reserve (FFR), coronary flow reserve (CFR) and index of microcirculatory resistance (IMR) were measured using a 0.014 coronary temperature and pressure-sensing guidewire (PressureWireCertus, ST. Jude Medical, MN, USA).

Timeline

Start date
2014-12-01
Primary completion
2015-12-31
Completion
2019-11-10
First posted
2019-11-20
Last updated
2019-11-20

Source: ClinicalTrials.gov record NCT04169516. Inclusion in this directory is not an endorsement.